Difference between Patoladigana Vasti versus standard control Triphala Kwath Lekhan Vasti in the management of Dyslipidemia Medoroga
Phase 3
- Conditions
- Health Condition 1: E889- Metabolic disorder, unspecified
- Registration Number
- CTRI/2024/02/062741
- Lead Sponsor
- Mahatma Gandhi Ayurveda College Hospital and Research Centre Salod Wardha
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- ot Yet Recruiting
- Sex
- Not specified
- Target Recruitment
- 0
Inclusion Criteria
Newly Diagnosed Dyslipedemia Patients with Serum Cholesterol > 20 mg/dl
Serum Triglycerides > 150 mg/dl
Serum HDL > 40 mg/dl
Serum VLDL > 30 mg/dl
Patient with Controlled Hypertension
Patient with Controlled type II Diabetes
Exclusion Criteria
Patients with age < 20 years and > 60 years
Serum Triglycerides > 150 mg/dl
Serum HDL < 40 mg/dl
Serum VLDL < 30 mg/dl
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method to asses the efficacy of Patoladi Vasti in Serum total Cholesterol level Triglycerides LDL HDL VLDLTimepoint: 7 Weeks
- Secondary Outcome Measures
Name Time Method to asses the efficacy of triphala kwath lekhan Vasti in Serum total Cholesterol level Triglycerides LDL HDL VLDLTimepoint: 1 week 7th week